Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2003
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1061951B1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
08/27/2003EP1042368B1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
08/27/2003EP0909277B1 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
08/27/2003EP0821693B1 Novel human cytomegalovirus dna sequences
08/27/2003EP0760685B1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
08/27/2003EP0706566B1 Conotoxins having acetylcholine receptor binding properties
08/27/2003CN1439056A Herpes viruses for immune modulation
08/27/2003CN1439022A Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1438896A Vaccine comprising a tick cement protein
08/27/2003CN1438894A Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking LFA-1 medicated adhesion
08/27/2003CN1438874A Powder compositions
08/27/2003CN1438247A Anti-mastitis causative-agent composite yolk antiboy for milk cow and its preparation and use
08/27/2003CN1438246A Anti-yellow-dysenteryÒÇüanti-white-dysentery causative-agent yolk antibody for young pig and its preparation and use
08/27/2003CN1438245A Infectious causative-agent related egg-yolk antibody preparation and use thereof
08/27/2003CN1438244A Self-body immunity-disease related egg-yolk atibody preparation method and use thereof
08/27/2003CN1438238A Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof
08/27/2003CN1438035A Composition for promoting sexual gland growth of male fish
08/27/2003CN1438034A Composition for promoting sexual gland growth of female fish
08/27/2003CN1119415C Clone and expression of anti-CA125 bifunctional genetically engineered antibody
08/27/2003CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610834 Human IgM antibodies to chemokine receptors
08/26/2003US6610833 Hybridoma cell line; immunoglobulins; can use in treating human immunodeficiency virus infections
08/26/2003US6610821 Cyclic peptide of given amino acid sequence; can use to improve drug delivery process, inhibit angiogenesis, increase vasopermeability; treatment of autoimmune and inflammatory diseases
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610661 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
08/26/2003US6610659 Use of heat shock protein 70 preparations in vaccination against cancer and infectious disease
08/26/2003US6610630 Selectivity adsorption immunoglobulins
08/26/2003US6610529 Recombinant bacterial system with environmentally limited viability
08/26/2003US6610517 Compartmentalization of recombinant polypeptides in host cells
08/26/2003US6610510 Human Cerberus proteins and related nucleic acids are provided. Included are proteins comprising a human cerberus domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be
08/26/2003US6610506 Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same
08/26/2003US6610501 Porcine protein and uses thereof
08/26/2003US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function
08/26/2003US6610473 Peptides for inhibiting HPV E6-proteins
08/26/2003US6610329 Compositions for the delivery of antigens
08/26/2003US6610310 Immunology response; side effect reduction
08/26/2003US6610309 Vaccines; mixture of antigen and water solubility organometallic compound
08/26/2003US6610308 Immunostimulant emulsion
08/26/2003US6610307 Immunity against pasteurella haemolytica leukotoxin
08/26/2003US6610306 For therapy, prophylaxis and diagnosis of non-symptomatic gonococcal infection or symptomatic disease and non-symptomatic meningococcal infection and symptomatic disease
08/26/2003US6610305 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
08/26/2003US6610303 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them
08/26/2003US6610301 Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
08/26/2003US6610300 Clostridium perfringens vaccine
08/26/2003US6610297 Compositions for treating allergies that include either BSW17 mimotope peptides or antibodies raised against BSW17 mimotope peptides. Also disclosed are methods for the treatment of allergies which involve administration of BSW17 mimeotope
08/26/2003US6610295 HCMV glycoproteins B and H have been identified. The gB protein is encoded by DNA in the HindIII F fragment of the HCMV genome lying between 1378 and 4095 bases from the F/D boundary. The gH protein is encoded by DNA in the HindIII L
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610293 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/26/2003US6610044 Method for genetic immunization
08/26/2003CA2220063C Acellular pertussis vaccines and methods of preparation thereof
08/21/2003WO2003069346A2 Diagnostic method for stroke
08/21/2003WO2003068993A1 Method for isolation and purification of expressed gene products in vitro
08/21/2003WO2003068974A2 YkuR POLYNUCLEOTIDES AND POLYPEPTIDES
08/21/2003WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene
08/21/2003WO2003068959A1 Novel screening method
08/21/2003WO2003068954A2 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003WO2003068942A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
08/21/2003WO2003068940A2 Complexes and methods of using same
08/21/2003WO2003068938A2 Human fetal bladder-derived epithelial cells
08/21/2003WO2003068933A2 Optimization of gene sequences of virus-like particles for expression in insect cells
08/21/2003WO2003068925A2 Production of a protein delivery system for in vivo therapeutic treatment
08/21/2003WO2003068923A2 Signal for packaging of influenza virus vectors
08/21/2003WO2003068822A2 De-immunized (poly)peptide constructs
08/21/2003WO2003068819A1 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
08/21/2003WO2003068816A1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
08/21/2003WO2003068815A2 Mhc class ii peptide epitope of 5t4 antigen
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068804A2 Novel insect cell line
08/21/2003WO2003068800A2 Isolated peptides which bind to hla molecules and uses thereof
08/21/2003WO2003068261A2 Means and methods for altering the motility of the gastrointestinal tract
08/21/2003WO2003068260A1 Antibody-containing solution pharmaceuticals
08/21/2003WO2003068259A1 Antibody-containing solution pharmaceuticals
08/21/2003WO2003068258A1 7s immunoglobulin for treatment of choroidal neovascularisation_
08/21/2003WO2003068257A1 Cancer therapy
08/21/2003WO2003068201A2 High affinity antibody having a tcr-like specificity and use in detection and treatment
08/21/2003WO2003068197A1 Method for systemic drug delivery through the nail
08/21/2003WO2003068190A1 Intracellular delivery of therapeutic agents
08/21/2003WO2003068169A2 Stabilized synthetic immunogen delivery system
08/21/2003WO2003068163A2 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
08/21/2003WO2003068151A2 Human antibodies for therapy against vaccinia or smallpox
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003068145A2 Herbal immune system stimulant
08/21/2003WO2003068144A2 Cytotoxic agents
08/21/2003WO2003059385A3 Hiv vaccine and method of use
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003037254A3 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
08/21/2003WO2003033674A3 Human antibodies that have mn binding and cell adhesion-neutralizing activity
08/21/2003WO2003029451A3 Histone deacetylase 9
08/21/2003WO2003024404A3 Chemokines as adjuvants of immune response
08/21/2003WO2003022881A3 Phenotype-determining virulence genes of pseudomonas aeruginosa for colonization and persistence in human beings, animals and plants, uses of said gene and associated proteins
08/21/2003WO2003018052A8 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
08/21/2003WO2002098459A3 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
08/21/2003WO2002095027A3 Immunostimulatory oligodeoxynucleic molecules
08/21/2003WO2002082075A3 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
1 ... 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 ... 1823